Cancer Biology & Therapy
Volume 23, 2022 - Issue 1
Research Paper
High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting
, , 
&
Jacob J. Adashekc Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, MD, USACorrespondence[email protected]
https://orcid.org/0000-0003-4272-312XView further author information
https://orcid.org/0000-0003-4272-312XView further author information & Razelle Kurzrockd MCW Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, WIS, USA;e Worldwide Innovative Network (WIN) for Personalized Cancer Therapy, Paris, Francehttps://orcid.org/0000-0003-4110-1214View further author information
https://orcid.org/0000-0003-4110-1214View further author information